| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 30-Nov-08 | 31-Aug-08 | | Total Revenue | 7,597 | 4,233 | 23,429 | 12,562 | | Cost of Revenue | 6,300 | 3,120 | 17,910 | 9,974 | | | Gross Profit | 1,297 | 1,113 | 5,519 | 2,588 | | | Operating Expenses | | Research Development | 150 | 257 | 441 | 577 | | Selling General and Administrative | 2,277 | 2,041 | 5,341 | 5,473 | | Non Recurring |
-
|
-
| 1,788 | (796) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,130) | (1,185) | (2,051) | (2,666) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21 | 6 |
-
|
-
| | Earnings Before Interest And Taxes | (1,109) | (1,179) | (2,051) | (2,666) | | Interest Expense |
-
|
-
| 85 | 30 | | Income Before Tax | (1,109) | (1,179) | (2,136) | (2,696) | | Income Tax Expense |
-
| (13) | 655 | (678) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,109) | (1,166) | (2,791) | (2,018) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,109) | (1,166) | (2,791) | (2,018) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,109) | ($1,166) | ($2,791) | ($2,018) |
|
0.16% Nasdaq 
Income Statement
